Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


European Journal of Endocrinology, Vol 133, Issue 4, 467-474
Copyright © 1995 by European Society of Endocrinology
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Molnar, M
Right arrow Articles by Hertelendy, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Molnar, M
Right arrow Articles by Hertelendy, F

Articles

Signal transduction in rat myometrial cells: comparison of the actions of endothelin-1, oxytocin and prostaglandin F2 alpha

M Molnar and F Hertelendy

Dept. of Obstetrics and Gynecology, St. Louis University School of Medicine, Missouri, USA.

The objectives of this study were to evaluate and compare the actions of endothelin-1 (ET-1), oxytocin, prostaglandin F2 alpha (PGF2 alpha) and inositol 1,4,5-trisphosphate (IP3) on 45Ca2+ mobilization in permeabilized rat myometrial cells and to examine the activation of the inositol lipid cycle in intact myocytes. Cells were isolated from late pregnant rat myometrium and used as confluent monolayers after a single passage. All four agonists caused a biphasic release of 45Ca2+ from non-mitochondrial pool(s), with the rank order of potency: oxytocin > PGF2 alpha > ET-1 > IP3. Inhibitors of phospholipase C blocked ET-1- and oxytocin-promoted but not PGF2 alpha-promoted 45Ca2+ efflux. Similarly, heparin, an IP3 receptor blocker, failed to inhibit PGF2 alpha-induced 45Ca2+ release while inhibiting the action of the other agonists. Endothelin-1 and oxytocin stimulated inositol phosphate accumulation at concentrations similar to those that promoted 45Ca2+ efflux, whereas about 100 times higher concentrations of PGF2 alpha were needed to activate this signaling pathway in intact cells. It is concluded that the primary action of PGF2 alpha in myometrial cells is to enhance Ca2+ influx, whereas oxytocin and ET-1 receptors are coupled to phospholipase C, generating IP3 and raising the intracellular concentration of free Ca2+ from intracellular as well as extracellular sources.


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
B. Y. Kim, C.-H. Cho, D.-K. Song, K.-C. Mun, S.-I. Suh, S.-P. Kim, D.-H. Shin, B.-C. Jang, T. K. Kwon, S.-D. Cha, et al.
Ciglitizone inhibits cell proliferation in human uterine leiomyoma via activation of store-operated Ca2+ channels
Am J Physiol Cell Physiol, February 1, 2005; 288(2): C389 - C395.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. Laporte, A. Hui, and I. Laher
Pharmacological Modulation of Sarcoplasmic Reticulum Function in Smooth Muscle
Pharmacol. Rev., December 1, 2004; 56(4): 439 - 513.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. L. Rigby, R. Barhoumi, R. C. Burghardt, P. Colleran, J. A. Thompson, D. D. Varner, T. L. Blanchard, S. P. Brinsko, T. Taylor, M. K. Wilkerson, et al.
Mares with Delayed Uterine Clearance Have an Intrinsic Defect in Myometrial Function
Biol Reprod, September 1, 2001; 65(3): 740 - 747.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Phillippe, T. Saunders, and A. Basa
Intracellular mechanisms underlying prostaglandin F2alpha -stimulated phasic myometrial contractions
Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E665 - E673.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Naze, H. Le Stunff, L. Dokhac, G. Thomas, and S. Harbon
Activation of Phospholipase D by Endothelin-1 in Rat Myometrium. Role of Calcium and Protein Kinase C
J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 15 - 23.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 European Society of Endocrinology.